CI - CIK 0001739940
The table below shows Cigna Group's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$4.41B | -$2.10B | -$5.17B | $3.10B | -$3.61B | $2.98B |
| Dividends paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15.00M |
Cigna Group reported operating cash flow of $9.60B for fiscal year 2025. That is down 7.4% from $10.36B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $4.03B (FY 2016) to $9.60B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B |
| Financing cash flow | -$6.42B | -$7.65B | -$4.29B | -$11.24B | -$8.21B | -$8.53B |